ORMP.OB Insider Trading Activity and SEC Form 4 Filings
ORMP.OB insider trading summary
No open-market insider purchases or sales of Oramed Pharmaceuticals Inc. (ORMP.OB) have been reported on SEC Form 4 in the past 12 months.
Latest ORMP.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 4, 2011 | Leonard Sank | Director | Buy | $300K (937,500 @ $0.32) |
| Sep 27, 2011 | Zeev Bronfeld | 10% Owner | Sell | $98K (350,000 @ $0.28) |
| Mar 31, 2011 | Zeev Bronfeld | 10% Owner | Buy | $250K (781,250 @ $0.32) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.